Global Schizophrenia Therapeutics Market Growth (Status and Outlook) 2023-2029

Global Schizophrenia Therapeutics Market Growth (Status and Outlook) 2023-2029

Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.

LPI (LP Information)' newest research report, the “Schizophrenia Therapeutics Industry Forecast” looks at past sales and reviews total world Schizophrenia Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Schizophrenia Therapeutics sales for 2023 through 2029. With Schizophrenia Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Schizophrenia Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Schizophrenia Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Schizophrenia Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Schizophrenia Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Schizophrenia Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Schizophrenia Therapeutics.

The global Schizophrenia Therapeutics market size is projected to grow from US$ 9600.4 million in 2022 to US$ 10890 million in 2029; it is expected to grow at a CAGR of 1.8% from 2023 to 2029.

The second-generation antipsychotic drugs segment accounted for the majority market shares because these drugs involve less side effects in comparison to their predecessors. The second-generation antipsychotic drugs are also called as atypical antipsychotic drugs. The increased efficacy and reduced side effects of these drugs improves the negative symptoms, decreases extrapyramidal side-effects (EPSE), and normalizes the level of prolactin. The improvement in negative and cognitive symptoms and the reduction in occurrences of EPSE is attributed to their antagonizing action on serotonin or 5-HT2A receptors. This in turn, will boost the segment’s growth throughout the estimated period.

This report presents a comprehensive overview, market shares, and growth opportunities of Schizophrenia Therapeutics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
First-Generation Antipsychotic Drugs
Second-Generation Antipsychotic Drugs
Third-Generation Antipsychotic Drugs

Segmentation by application
Hospitals
Clinics
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Alkermes
AbbVie
Amgen
Bristol-Myers Squibb

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Schizophrenia Therapeutics Market Size by Player
4 Schizophrenia Therapeutics by Regions
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Schizophrenia Therapeutics Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings